See more : IF Bancorp, Inc. (IROQ) Income Statement Analysis – Financial Results
Complete financial analysis of Syra Health Corp. Class A Common Stock (SYRA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Syra Health Corp. Class A Common Stock, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Bayer Aktiengesellschaft (BAYNN.MX) Income Statement Analysis – Financial Results
- Access Intelligence Plc (ACC.L) Income Statement Analysis – Financial Results
- Pacira BioSciences, Inc. (PCRX) Income Statement Analysis – Financial Results
- PayPal Holdings, Inc. (PYPL) Income Statement Analysis – Financial Results
- Bic Camera Inc. (3048.T) Income Statement Analysis – Financial Results
Syra Health Corp. Class A Common Stock (SYRA)
About Syra Health Corp. Class A Common Stock
Syra Health Corp., a healthcare services company, provides health education, population health management, behavioral and mental health, healthcare workforce, and digital health services in the United States. It offers health education services, including medical communications, patient education, and healthcare training; and population health management services, such as analytics as a service, epidemiology, and health equity analytics solutions. The company also engages in developing Syrenity, an on-demand telehealth platform for mental health services. In addition, the company provides healthcare staffing solutions; and digital health solutions comprising digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. Syra Health Corp. was incorporated in 2020 and is headquartered in Carmel, Indiana.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.52M | 5.62M | 1.41M | 0.00 |
| Cost of Revenue | 4.10M | 4.56M | 979.62K | 0.00 |
| Gross Profit | 1.41M | 1.06M | 430.35K | 0.00 |
| Gross Profit Ratio | 25.60% | 18.90% | 30.52% | 0.00% |
| Research & Development | 240.05K | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.01M | 3.11M | 416.01K | 0.00 |
| Selling & Marketing | 0.00 | 390.27K | 39.59K | 0.00 |
| SG&A | 4.01M | 3.11M | 416.01K | 4.27K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.30M | 3.15M | 433.63K | 4.27K |
| Cost & Expenses | 8.40M | 7.71M | 1.41M | 4.27K |
| Interest Income | 2.94K | 63.00 | 0.00 | 0.00 |
| Interest Expense | 53.69K | 28.53K | 0.00 | 0.00 |
| Depreciation & Amortization | 48.77K | 14.85K | 207.00 | 51.20K |
| EBITDA | -2.84M | -2.07M | -3.07K | -4.27K |
| EBITDA Ratio | -51.42% | -36.93% | -0.22% | 0.00% |
| Operating Income | -2.89M | -2.09M | -3.28K | -4.27K |
| Operating Income Ratio | -52.36% | -37.20% | -0.23% | 0.00% |
| Total Other Income/Expenses | -50.74K | -28.47K | 0.00 | -46.93K |
| Income Before Tax | -2.94M | -2.12M | -3.28K | -4.27K |
| Income Before Tax Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
| Income Tax Expense | 0.00 | 63.00 | 0.00 | -51.20K |
| Net Income | -2.94M | -2.12M | -3.28K | -4.27K |
| Net Income Ratio | -53.28% | -37.71% | -0.23% | 0.00% |
| EPS | -0.60 | -0.36 | 0.00 | 0.00 |
| EPS Diluted | -0.60 | -0.29 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 4.88M | 5.86M | 7.28M | 5.98M |
| Weighted Avg Shares Out (Dil) | 4.88M | 7.28M | 7.28M | 5.98M |
Syra Health Forms Strategic Partnership with Maricopa County to Address Healthcare Disparities
Syra Health to Participate in the Lytham Partners Fall 2023 Investor Conference
Syra Health to Participate in Upcoming Healthcare and Investor Conferences
Syra Health Secures $4.75 Million Contract to Bolster Mental Health Services in Washington, D.C.
Syra Health Corp. Announces Closing of Initial Public Offering
Kingswood Announces Closing of Syra Health Corp. Initial Public Offering
Source: https://incomestatements.info
Category: Stock Reports